Almouzain Lubna, Hamilton Fiona L, Chard Declan, Stevenson Fiona
Research Department at Primary Care and Population Health, Institution of Epidemiology, University College of London, London, UK.
Assistant Professor at Clinical Pharmacy Department, King Saud University, Riyadh, Saudi Arabia.
Mult Scler J Exp Transl Clin. 2024 Jun 11;10(2):20552173241262181. doi: 10.1177/20552173241262181. eCollection 2024 Apr-Jun.
Decision-making about treatment when planning a pregnancy (family planning) is complex for women living with multiple sclerosis (MS). Decision tools can help this process, in 2016 MS Trust launched their online digital treatment decision tool to support people with MS.
To evaluate user-experience of this tool by exploring women's opinions about its content, interface, and usefulness in the context of family planning; and to synthesize recommendations to improve the tool.
Thirty participants qualitatively evaluated the tool using Think Aloud methodology. Sessions were conducted online using Microsoft Teams and were video recorded. Transcription was automated and data were thematically analyzed.
Women's first impression was that the tool presented a lot of information at once, which was difficult to take in, and they found it difficult to navigate. Although the tool was helpful in allowing them to compare treatment options, the filters were confusing, and the information related to pregnancy sometimes contradicted advice from their healthcare practitioners. They suggested rewording the pregnancy recommendations and filters, updating some content, and making some changes to the interface to meet users' cognitive needs.
The MS Trust treatment decision tool is excellent in helping women with treatment choices at initial diagnosis. However, it is not currently as useful when considering family plans. Recommendations were conveyed to MS Trust where some are now applied to the new live version and the rest are to be considered for future updating projects.
对于患有多发性硬化症(MS)的女性而言,在计划怀孕(计划生育)时进行治疗决策是复杂的。决策工具可以辅助这一过程,2016年,MS信托基金推出了其在线数字治疗决策工具,以支持MS患者。
通过探讨女性对该工具在计划生育背景下的内容、界面及有用性的看法,评估该工具的用户体验;并综合提出改进该工具的建议。
30名参与者采用出声思考法对该工具进行定性评估。使用Microsoft Teams在线进行评估过程,并进行视频录制。转录过程自动完成,对数据进行主题分析。
女性的第一印象是该工具一次性呈现了大量信息,难以理解,且她们发现难以导航。尽管该工具有助于她们比较治疗方案,但筛选器令人困惑,与怀孕相关的信息有时与她们的医疗保健从业者的建议相矛盾。她们建议重新措辞怀孕相关建议和筛选器,更新一些内容,并对界面进行一些更改以满足用户的认知需求。
MS信托基金的治疗决策工具在帮助女性在初次诊断时做出治疗选择方面非常出色。然而,在考虑计划生育时,它目前不太有用。建议已传达给MS信托基金,其中一些建议现已应用于新的实时版本,其余建议将在未来的更新项目中予以考虑。